Table 1.
Feb-May | Jan-Dec | |||||||
---|---|---|---|---|---|---|---|---|
Number of cases tested | 2018 (n=22.609) | 2019 (n=26.752) | 2020 (n=18.864) | Total (n=68.22) | 2018 (n=62.061) | 2019 (n=67.464) | 2020 (n=56.871) | Total (n=186.396) |
Women | 19.990 (88.4%) | 23.902 (89.3%) | 15.674 (83.1%) | 59.566 (87.3%) | 54.995 (88.6%) | 59.358 (88.0%) | 50.884 (89.5%) | 165.237 (88.6%) |
Ig M+ | 434 (1.92%) | 816 (3.1%) | 258 (1.37%) | 1.508 (2.21%) | 1.104 (1.78%) | 1.912 (2.83 %) | 779 (1.37%) | 3.795 (2.04%) |
Women Ig M+ | 352 (1.76%) | 615 (2.57%) | 213 (1.35%) | 1.180 (1.98%) | 840 (1.35%) | 1.572 (2.33%) | 606 (1.06 %) | 3.018 (1.62%) |
Men Ig M+ | 82 (3.13%) | 201 (7.0%) | 45 (1.41%) | 328 (3.79%) | 264 (3.73%) | 340 (4.19%) | 173 (2.88%) | 777 (3.67%) |